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Abstract
Introduction—Information on folate and vitamin B12 deficiency rates in Guatemala is essential 
to evaluate the current fortification program. The objectives of this study were to describe the 
prevalence of folate and vitamin B12 deficiencies among women of childbearing age (WCBA) in 
Guatemala and to identify vulnerable populations at greater risk for nutrient deficiency.
Methods—A multistage cluster probability study was designed with national and regional 
representation of nonpregnant WCBA (15–49 years of age). Primary data collection was carried 
out in 2009–2010. Demographic and health information was collected through face-to-face 
interviews. Blood samples were collected from 1,473 WCBA for serum and red blood cell (RBC) 
folate and serum vitamin B12. Biochemical concentrations were normalized using geometric 
means. Prevalence rate ratios were estimated to assess relative differences among different 
socioeconomic and cultural groups including ethnicity, age, education level, wealth index and 
rural versus urban locality.
Results—National prevalence estimates for deficient serum (<10 nanomoles per liter [nmol/L]) 
and RBC folate (<340 nmol/L) concentrations were 5.1% (95% CI 3.8, 6.4) and 8.9% (95% CI 
6.7, 11.7), respectively; for vitamin B12 deficiency (<148 pmol/L) 18.5% (95% CI 15.6, 21.3). 
Serum and RBC folate deficiency prevalences were higher for rural areas than for urban areas 
(8.0% vs. 2.0% and 13.5% vs. 3.9%, respectively). The prevalence of RBC folate deficiency 
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showed wide variation by geographic region (3.2%–24.9%) and by wealth index (4.1%–15.1%). 
The prevalence of vitamin B12 deficiency also varied among regions (12.3% –26.1%).
Conclusions—In Guatemala, folate deficiency was more prevalent among indigenous rural and 
urban poor populations. Vitamin B12 deficiency was widespread among WCBA. Our results 
suggest the ongoing need to monitor existing fortification programs, in particular regarding its 
reach to vulnerable populations.
Keywords
Prevalence; serum and red blood cell folate deficiency; vitamin B12; deficiency; women of 
childbearing age; Guatemala
Background
Micronutrient deficiencies and food insecurity can lead to severe, acute, or chronic 
malnutrition for women and children around the world [1, 2]. Micronutrient deficiencies 
among women of childbearing age (WCBA) (15–49 years of age) can have adverse effects 
on birth outcomes, increasing the risk for sequelae such as neural tube defects (NTDs) and 
slow intellectual and motor development among offspring [3, 4]. Folate and vitamin B12 
deficiencies, specifically, have significant public health consequences, including an 
increased prevalence of NTDs [5, 6] and of cardiovascular diseases [7, 8]. Micronutrient 
deficiencies and malnutrition historically have been chronic problems in Central America 
[9].
Fortifying food products has been a principal strategy in Central America to reduce various 
micronutrient deficiencies, including that of folic acid. In 2003 Guatemala aligned their folic 
acid fortification levels to the regional levels of 1.80 mg/kg [10, 11], while also selectively 
fortifying MASECA® corn masa flour [12].
Imhoff-Kunsch et al. (2007) studied the effects of fortification of wheat flour with iron and 
folic acid using data from the Living Standards Measurement Survey for Guatemala [13]. 
Data from this survey demonstrated that fortified wheat flour provided 71% and 78% of the 
estimated average requirements (EARs) for folate for women identified as being nonpoor or 
living in urban areas, respectively; in contrast, fortified wheat flour provided only 4.7%, 
15.5%, and 10.5% of EARs to women identified as extremely poor, living in rural areas, or 
indigenous, respectively [13]. These data also demonstrated that fortified foods were more 
available and affordable in urban areas, for the nonpoor, and among those with cultural 
preferences for specific types of foods. However similar data were not obtained for age, 
education and wealth index. Nutritional needs differ by age, particularly for WCBA and 
educational level. Education level is important because it aids in informed decision making 
about nutrition and diet. Wealth index is important because it can determine differences in 
population and health indicators between the index levels.
Ours is the first study in Guatemala to provide information on the folate and vitamin B12 
status of nonpregnant WCBA, taking into account different demographic and geographic 
characteristics. The major aim of this study was to assess the overall impact of the 
Guatemala fortification program by describing national and regional prevalences of folate 
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and vitamin B12 deficiencies and by identifying vulnerable populations at risk of not 
benefiting from existing fortification strategies.
Methods
Guatemalan Population
In 2010 the total population of Guatemala was 14,361,666. Women made up slightly more 
than half of that total and 41% were indigenous, 51% lived below the poverty line, 51% 
lived in rural areas, and 29% were 15–49 years of age [14].
Study Population and Sample Selection—Our study used the sampling frame from 
the Encuesta Nacional de Salud Materno Infantil (ENSMI). The ENSMI, conducted in 2008, 
used a complex, multistage probability design of the civilian, noninstitutionalized 
Guatemalan population to select 734 sectors, from which 26,000 men, women, and children, 
stratified by department (province) and urban and rural settings were selected [15]. The 
ENSMI identified all sampled households with WCBA and children 6–59 months of age. 
Our study, the Encuesta Nacional de Micronutrientes (ENMICRON), selected a subset (246 
sectors) of the household sampling frame surveyed by the ENSMI. Using this subset, we 
assessed the micronutrient status of a sample of nonpregnant WCBA and children 6–59 
months of age to obtain national and regional representation. The minimum sample size 
required was 150 nonpregnant WCBA in each region in order to detect a minimum 
difference of 10% prevalence with a relative standard error of ≤30%, given a survey design 
effect of 1.5. Primary data collection was conducted by the Ministry of Health in 2009–
2010.
The selected households were screened to ensure that previously identified nonpregnant 
WCBA were still in residence. Informed consent was obtained and WCBA were interviewed 
using a short, standardized questionnaire, after which blood was drawn. The household 
interviews were conducted in Spanish or Mayan. The ENMICRON used the ENSMI self-
reported data on sociodemographic information using the following ENSMI variables: area 
(rural or urban), ethnicity (indigenous or nonindigenous), educational level (none, primary, 
and secondary or higher), wealth index (low, middle, or high) and region to identify 
vulnerable populations. Area was defined by the location of the household. Urban areas 
included large cities, small cities (population over 50,000) and towns (population over 
2,500. All rural areas were locations with populations of <2,500). Participants who reported 
they were Mayan were categorized as indigenous. Participants who reported as mestizos or 
White were categorized as nonindigenous. A woman’s education level was based on the 
highest grade or level of education completed. Wealth index was established by information 
on household characteristics (e.g., building materials, number of rooms, water source, and 
type of toilet) [16]. Due to regional differences in the distribution of rural vs urban 
population, indigenous population, wealth and dietary customs (preference for staples such 
as rice, corn or wheat) we selected region as an independent variable.
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Whole blood was collected from nonfasting participants. EDTA and nonanticoagulated 
whole blood vacutainers were refrigerated and protected from light for 2–3 days prior to 
being processed at the central laboratory in Guatemala City. Folate has been shown to be 
stable under such conditions [17]. Serum and EDTA whole blood hemolysate (whole blood 
diluted 1:11 with 10 g/L ascorbic acid) were stored at ≤−20°C for less than 3 months, and at 
≤−80°C for a year until shipment on dry ice to the CDC laboratory. During 2011–2013, the 
CDC laboratory conducted biochemical analyses for serum and RBC folate concentrations 
by microbiologic assay (MBA) [18] and for serum vitamin B12 by the RocheR electro-
chemiluminescence assay on the E-170 instrument platform (Roche Vitamin B12 assay 
package insert, 2007–8, V4). The mean coefficients of variation for three quality control 
(QC) pools measured in each assay in duplicate for serum folate (8.4–49.5 nmol/L), whole 
blood folate (191–401 nmol/L), and serum vitamin B12 (212–395 pmol/L were 8.4%–9.4%, 
7.5%–9.4%, and 4.0%–4.4%, respectively.
To assess folate status, we used two biomarkers: serum and RBC folate. The serum folate 
concentration better reflects recent dietary intake of folate. Because the highest level of 
serum folate typically occurs approximately 45–90 minutes after eating, serum folate ideally 
should be measured under fasting conditions. RBC folate concentrations reflect tissue stores 
and folate intake during the past 120 days and, thus, are less influenced by recent 
consumption of folate-containing foods. We used established deficiency criteria as cutoff 
points for the analyses: <10 nmol/L for serum folate (SF) and <340 nmol/L for RBC folate 
(RBCF) [19]. The cutoff point for identifying vitamin B12 deficiency was <148 pmol/L; for 
marginal vitamin B12 deficiency, it was defined as 148–221 pmol/L [20]. We used a 5% 
threshold criterion above which prevalences of low SF, RBCF, and vitamin B12 were 
indicative of a public health concern [21].
Quality Assurance
Quality assurance procedures were instituted for each phase of the study. Development of 
survey instruments involved expert review and pretesting in the community. Interviewers 
and phlebotomists were trained for 3 weeks; training included practice interviews and blood 
drawing from patients at health centers and in nonstudy households. In the data collection 
phase, any questionnaire that was incomplete or contained an error was returned to the 
interviewer and, when appropriate, they went back to the household for correction. Also, a 
subsample of households was recontacted to ensure that households listed as ineligible were 
designated correctly and that eligible women were not missed. Trained staff obtained and 
entered data twice to ensure accuracy and completeness.
Analytical and Statistical Methods
The crude prevalence point estimates and 95% confidence intervals (CIs) for SF and RBCF 
deficiencies and for vitamin B12 and vitamin B12 marginal deficiencies were calculated. 
Variances were calculated by procedures that accounted for the complex survey design and 
for ratio adjustments used to produce the sample weights. Comparisons using the selected 
variables were done using prevalence risk ratios (PRRs) for serum and RBC folate and 
vitamin B12 deficiencies. To facilitate interpretations, adjusted prevalence risk ratios were 
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calculated from the overall logistic regression models using PREDMARG statement in 
SUDAAN [22, 23]. The adjusted percentage was generated using the logistic regression 
model to estimate the probability of deficiency status, averaging the distribution of 
covariates among the entire weighted sample. The reported risk estimates were adjusted for 
survey design, as well as the covariates listed previously.
Geometric means for SF, RBCF, and vitamin B12 were calculated to normalize the 
distribution. Differences in the sociodemographic variables were tested using t-tests derived 
from linear regression models (Proc Regress SUDAAN). We used multiple linear 
regressions to adjust for the selected variables because the magnitudes of the correlations 
were modest or weak (0.01–0.35). The Taylor series approximation was used to obtain the 
standard errors [24]. All analyses were performed using SUDAAN statistical software 
(version 9.3; Research Triangle Institute, Research Triangle Park, NC).
The Guatemalan Ministry of Health requested that the study protocol be reviewed by the 
CDC Institutional Review Board (IRB) in Atlanta, Georgia, in the United States. CDC 
accepted this request, and the protocol was approved by the CDC IRB.
Results
Response Rates and Characteristics of Participants
We identified 1,475 households and data were collected on 1,453 (98.5%) nonpregnant 
WCBA. Blood samples were obtained from 1,448 eligible women. Table 1 shows the 
general characteristics of the ENMICRON sample of nonpregnant WCBA in Guatemala: 
53.3% lived in rural areas, 61.9% were of nonindigenous ethnicity, 22.2% were 15–19 years 
of age, 19.1% had no education, and 31.6% were classified in the low wealth tertile. The 
ENMICRON population reflects the ENSMI data characteristics (data not show).
In Tables 2 through 4, results are presented by type of deficiency (SF and RBCF and vitamin 
B12 and vitamin B12 marginal deficiencies) first, at the national level; second, based on the 
variables of area, ethnicity, age, education level, and wealth index; and finally by geographic 
region within Guatemala. The data are then presented as geometric means of serum and 
RBC folate and serum vitamin B12 stratified by the selected variables.
Serum and RBC Folate Deficiency Prevalences at the National Level and by Area, 
Ethnicity, Age, Education Level, and Wealth Index
The national prevalence estimates of folate deficiency based on SF and RBCF 
concentrations were 5.1% (95% CI, 3.8, 6.4) and 8.9% (95% CI, 6.7, 11.7), respectively. 
The prevalence of folate deficiency based on SF varied by area, ethnicity, age, education 
level, and wealth index (Table 2). We found a higher overall prevalence in rural areas than 
in urban areas (8.0% vs. 2.0%), and the adjusted PRR reached significance (2.4 [95% CI, 
1.1, 4.1]). Also, women in the low wealth index had a higher prevalence of serum folate 
deficiency than women in the middle and high wealth indices (9.7% vs. 5.4% and 0.8 %, 
respectively). The adjusted PRRs for women in the low and middle wealth indices were 
significantly higher than that for women in the high wealth index (5.4 [95% CI 1.7, 16.6] 
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and 4.3 [95% CI 1.3, 13.9]), respectively). The strongest predictors of SF deficiency were 
residing in a rural area and being in the low and middle wealth indices.
The prevalence estimates of RBCF deficiency also varied across most variables and were 
similar to those for SF deficiency (Table 2). We found a higher prevalence of deficiencies in 
rural areas than in urban areas (13.5% vs. 3.9%), with a significant adjusted PRR (2.7 [95% 
CI 1.03, 7.1]).
Vitamin B12 and Vitamin B12 Marginal Deficiencies at the National Level and by Area, 
Ethnicity, Age, Education Level, and Wealth Index
The national prevalence estimates of vitamin B12 and vitamin B12 marginal deficiencies 
were 18.5% (95% CI 15.6, 21.3) and 30.2% (95% CI 27.3, 33.1), respectively (Table 3). The 
prevalence of B12 deficiency varied across all variables; however, the only adjusted PRRs 
reaching statistical significance were for women in the low or middle wealth index vs. those 
in the high wealth index (2.8 [95% CI 1.7, 4.8] and 1.6 [95% CI 1.02, 2.7], respectively). 
The prevalence of vitamin B12 marginal deficiency also varied; the only adjusted PRRs 
reaching statistical significance were for women 35–49 vs 15–19 years of age (0.7 [95% CI 
0.5, 0.9]) and in the low vs high wealth index (1.7 [95% CI 1.3, 2.3]).
Prevalence of Serum and RBC Folate Deficiencies and Vitamin B12 and Vitamin B12 
Marginal Deficiencies by Region
To identify vulnerable women within Guatemala, we compared study results by region 
(Table 4). The results revealed differences in the prevalences of SF and RBCF deficiencies 
ranging from 1.4–8.9, and 3.5–24.9, respectively, although only one area (Norte) showed a 
significantly higher adjusted PRR compared with that of the reference area (Metropolitana).
The prevalences of vitamin B12 deficiency ranged from 12.3% (95% CI 8.9, 16.7) in the 
Sur-Occidente to 26.1% (95% CI 19.5, 34.0) in the Sur-Oriente (Table 4). The prevalences 
of vitamin B12 marginal deficiency ranged from 21.5% (95% CI 12.6, 34.2) in the Petén to 
37.8% (95% CI 29.5, 46.9) in the Nor-Oriente. However, no significant differences were 
observed when each region was compared with the referent region (Metropolitana).
Geometric Means of Serum and RBC Folate and Vitamin B12 by the Selected Variables
The national geometric means and their distributions for SF and RBCF and vitamin B12 
were 30 nmol/L (95% CI 29, 31), 725 nmol/L (95% CI 710, 738), and 341 pmol/L (95% CI 
332, 349), respectively (Table 5, Figure 1). We found that rural areas had significantly lower 
geometric means of SF than urban areas (p < 0.001) as well as significantly lower mean 
concentrations among women in the lowest education levels and wealth indices. Similarly, 
for RBCF concentrations, we found significantly lower geometric means among women in 
rural areas; likewise, we found lower geometric means among women in the low wealth 
index than among women in the middle and high wealth indices. Geometric means of 
vitamin B12 were significantly higher for indigenous than for nonindigenous women and 
were significantly lower for women 15–19 years of age than for women 20–34 and 35–49 
years of age. In addition, there were significantly lower mean vitamin B12 concentrations 
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among women in the low wealth index than among women in the middle and high wealth 
indices.
Geometric Means of Serum and RBC Folate and Vitamin B12 by Region
Geometric means for SF, RBCF and vitamin B12 showed large variations across regions 
(Table 5). The Metropolitana region showed significantly higher SF and RBCF 
concentrations than several other regions. However, for vitamin B12 concentrations, the 
Metropolitana region showed significantly lower concentrations than the Sur-Occidente 
region.
Discussion
This is the first national and regional survey from Guatemala that provides information 
about SF and RBCF and vitamin B12 concentrations among nonpregnant WCBA. We 
demonstrated that prevalences estimates >5% for SF, RBCF and vitamin B12 deficiencies 
among this population should raise public health concern [21]. Based on our analyses, we 
potentially identified two vulnerable groups of WCBA in Guatemala: (1) women who were 
poor, especially younger women, residing in both urban and rural areas and (2) women of 
indigenous ethnicity.
• Poor urban women probably enjoyed proximity to fortified foods, but encountered 
barriers to access because of cost. Poor rural women had both limited access and 
availability. Food preferences and nutritional needs also might have varied by the 
age of the women.
• Indigenous women resided primarily in rural areas and were poor; they also likely 
retained many traditional food preferences. Based on the higher serum vitamin B12 
concentrations we identified among this population, their overall intake of meat 
might have been somewhat higher (than that of other group) most likely because 
they raised domesticated food animals or due to genetic factors.
These findings can be used to inform future fortification strategies and ensure that fortified 
staples reach vulnerable populations in Guatemala. These include (1) increasing the types of 
foods fortified (e.g., corn flour, sugar, and rice); (2) reducing the cost of fortified foods; (3) 
improving nutritional education, including culturally appropriate outreach to distinct target 
audiences (taking into consideration cultural factors such as dietary preferences); (4) 
implementing a national and regional monitoring program or programs to identify high-risk 
groups; and (5) implementing supplement programs for high-risk groups who have limited 
access to fortified staples.
Ideally, assessment of the effects of flour fortification on blood concentrations of SF and 
RBCF should include the analysis of data from the target populations before and after food 
fortification. In our case, prefortification data were not available. Postfortification data were 
available for other countries, so we compared our findings with those of other countries in 
the region and with those of the United States; we selected studies reporting results based on 
microbiologic assay (MBA) or MBA-equivalent data.
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Guatemala’s overall SF deficiency rate (5.1%) was higher than that reported from the 
postfortification period in the Dominican Republic (3.1%) [25] and Nicaragua (2.3%) [26]. 
Postfortification prevalence of RBCF deficiency in our study (8.9%) was slightly higher 
than that reported by the Dominican Republic (7.3%) [25], and much higher than that 
reported by Nicaragua (1.1%) [26]. Also, our RBCF deficiency prevalence rates were higher 
than rates reported for the U.S. postfortification period (1988–2010) among WCBA [27, 28], 
but the folate concentrations observed were somewhat higher than those reported for the 
U.S. prefortification period [27], from which we deduced a positive effect of the 
Guatemalan fortification program.
The observed differences in the prevalences of blood folate deficiency or blood folate 
concentration levels, or both, between Guatemala and other Central American countries and 
the United States might be explained by differences in population characteristics; differential 
access to fortified staples among population groups; and, possibly most importantly, because 
most of these other countries fortified multiple staples. In contrast to other countries, in 
Guatemala maize is the main staple and the majority of households consume maize flour in 
the form of masa made at home or obtained from small mills. While there is some voluntary 
fortification of masa flour, it might not have been accessible or available to the entire 
population. Populations who resided in urban areas and who were better educated and 
wealthier most likely had access to fortified flour and probably masa products. It remains to 
be seen whether the Guatemalan food fortification program could improve its effectiveness 
by fortifying additional food staples. This is especially important because folic acid has been 
shown to significantly reduce the risk of having a pregnancy affected by an NTD [5, 6].
Our study revealed that two regions in Guatemala differed from the other six regions in the 
prevalence of folate deficiencies, and that these differences could be explained by different 
population characteristics (e.g., proportion of rural and indigenous women). The Norte 
region showed the highest prevalences of serum and RBC folate deficiencies and had a 
population that was 84% rural and 88% indigenous (data not shown). In contrast, the 
Metropolitana and Petén regions showed the lowest prevalence of SF and RBCF 
deficiencies; these regions also tended to be more urban (76% and 52%, respectively) and to 
have smaller indigenous populations (15% and 22%, respectively).
Our study also found that vitamin B12 and vitamin B12 marginal deficiencies (19% and 
30%, respectively) were high among WCBA in Guatemala. A high prevalence of maternal 
vitamin B12 deficiency is an independent risk factor for NTDs [5, 30]. The results of our 
study for vitamin B12 deficiency were higher (18.5%) than the overall prevalence reported 
by Costa Rica (5%) [30], but lower than that reported among women in rural Mexico (28%) 
[31]. The high prevalence of vitamin B12 deficiency in Guatemala, as in other low or middle 
income countries, likely was related to an inadequate intake of dietary vitamin B12, due to a 
diet low in animal products [32, 33]. Contrarily, it was surprising to observe that the 
indigenous population showed higher geometric means of vitamin B12 levels than the 
nonindigenous populations. Further research on indigenous diets could assist in explaining 
these results.
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A major strength of our study was that survey data were collected via carefully designed, 
reliable procedures and a high response rate. Moreover, rigorous protocols were used in 
carrying out the field work and handling the biological samples, thus minimizing factors that 
could have compromised measurement of biomarkers. The study population was 
representative of the Guatemalan population of WCBA and was large enough to provide 
sufficient power for stable estimates within each of eight regions.
There were, however, several limitations to our analyses. First, ENMICRON was a cross-
sectional study and could not be used to determine causation; thus, we were not able to draw 
conclusions about either the benefits or safety of either folic acid fortification or intake using 
these data. Second, we were not able to compare our postfortification era estimates with 
prefortification estimates, however we could compare with neighboring countries that also 
fortify their food base. Third, we were not able to determine the causes of some of the 
disparities in prevalence because we did not assess dietary intake. Fourth, the estimation of 
the wealth index might have had an urban bias because some wealth index assets were not 
available in many rural areas, and data were not collected to include individual land 
resources and animals.
Conclusions
The folate fortification program undertaken in Guatemala might have improved serum and 
RBC folate levels; however, there were significant differences between groups of women 
based on region of residence and other characteristics. The differences revealed in this study 
identified vulnerable populations (populations at greater risk of folate and B12 deficiency) 
within Guatemala, including (1) women who were poor, especially young women, residing 
in both urban and rural areas, and (3) women of indigenous ethnicity. The greatest need 
existed where these characteristics co-occurred, as in the Norte region of Guatemala.
Mandatory fortification with folic acid in Guatemala may have benefitted regions with better 
access to folic acid-fortified products or staples with high folate content, but results were 
still below what would be expected from a fully effective fortification program (such as 
those seen in Chile [35,36], Costa Rica [37], and the United States [27]). It remains to be 
determined whether the Guatemalan food fortification program could improve its 
effectiveness and reach a greater proportion of the population through fortification of 
additional staples (e.g., maize flour). Such a strategy could be complemented by 
consideration of supplementation programs to reach the most vulnerable. Furthermore, the 
addition of vitamin B12 to the Guatemalan fortification program would have the potential to 
address high vitamin B12 deficiencies across all WCBA. These strategies would need to be 
supported by targeted educational outreach.
Our study is the first to provide national, regional, and subpopulation prevalence estimates 
for folate and vitamin B12 deficiency. As such, it can serve as a reference point to assess 
changes in these deficiencies over time, which would allow for identification of continuing 
disparities and provide a means to further refine the program.
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Table 1
Characteristics of non-pregnat women of childbearing age (15–49 years of age), ENMICRON* 2009–2010
ENMICRON
N N
(unweighted) (weighted) Percentage (%) 95% CI†
Area
  Rural 773 1,322,949 53.3 45.9, 60.1
  Urban 675 1,159,972 46.7 39.4, 54.1
Ethnicity
  Indigeneous 559 945,282 38.1 33.5, 42.7
  Non indigeneous 889 1,537,639 61.9 57.3, 66.4
Age (yrs.)
  15 – 19 233 551,918 22.2 19.6, 25.2
  20 – 34 525 832,324 33.5 29.3, 37.2
  35 – 49 690 1,098,679 44.3 40.2, 48.4
Education (yrs)
  None 314 473,973 19.1 45.0, 53.2
  Primary 715 1,219,185 49.1 27.2, 36.8
  Secondary or higher 419 789,763 31.8 15.9, 22.7
Wealth index (terciles)
  Low 478 784,571 31.6 24.6, 37..0
  Middle 538 860,869 34.7 29.4, 40.3
  High 432 837,481 33.7 27.9, 40.0
*
Encuesta Nacional de Micronutrientes
†
Confidence interval
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Table 2
Prevalence and unadjusted and adjusted prevalence risk ratios (PRR) of serum and red blood cell (RBC) folate 
deficiencies, ENMICRON, 2009–2010
N Unadjusted Adjusted
(unweighted) Prevalence PRR‡ (95% CI) PRR (95% CI)†
(95%CI)
Serum Folate Deficiency (<10 nmol/L)
National 1448 5.1 (3.8, 6.4)
Area
  Rural 773 8.0 (5.9, 10.7) 4.0 (2.1, 7.7)*** 2.4 (1.1, 4.1)***
  Urban 675 2.0 (1.2, 3.5) Referent Referent
Ethnicity
  Indigeneous 559 7.1 (5.0, 9.9) 1.8 (1.1, 2.9)* 1.2 (0.7, 2.1)
  Non-Indigeneous 889 3.9(2.7, 5.5) Referent Referent
Age (yrs.)
  15 – 19 233 3.1 (1.4, 6.8) Referent Referent
  20 – 34 525 4.5 (3.1, 6.6) 1.6 (0.7, 3.8) 1.3 (0.5, 3.0)
  35 – 49 690 6.5 (4.6, 9.2) 2.2 (0.9, 5.1) 1.6 (0.7, 4.0)
Education (yrs)
  None 314 10.7 (7.4,15.1) 5.9 (2.3, 15.3)*** 1.7 (0.6, 4.9)
  Primary 715 5.2 (3.7, 7.2) 2.9 (1.2, 7.4)** 1.2 (0.5, 3.0)
  Secondary or higher 419 1.8 (0.8, 4.2) Referent Referent
Wealth index (terciles)
  Low 478 9.7 (7.1,13.2) 11.7 (3.4, 38.5)*** 5.4 (1.7, 16.6)***
  Middle 538 5.4 (3.7, 7.9) 6.5 (2.1, 22.7)*** 4.3(1.3, 13.9)***
  High 432 0.8 (0.3, 2.6) Referent Referent
RBC Folate Deficiency (<340 nmol/L)
National 1448 8.9 (6.7, 11.7)
Area
  Rural 773 13.5 (9.9, 18.1) 3.4 (1.6, 7.1)** 2.7 (1.03, 7.1)*
  Urban 675 3.9 (2.0, 7.7) Referent Referent
Ethnicity
  Indigeneous 559 11.4 (7.8, 16.5) 1.6 (0.9, 2.6) 1.2 (0.7, 2.1)
  Non-Indigeneous 889 7.3 (4.9, 10.7) Referent Referent
Age (yrs.)
  15 – 19 233 8.1 (5.0, 12.8) Referent Referent
  20 – 34 525 8.4 (5.5, 12.6) 0.9 (0.5, 1.5) 0.8 (0.5, 1.4)
  35 – 49 690 9.7 (6.6, 13.9) 1.2 (0.6, 2.1) 1.1 (0.6, 2.1)
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N Unadjusted Adjusted
(unweighted) Prevalence PRR‡ (95% CI) PRR (95% CI)†
(95%CI)
Education (yrs)
  None 314 9.0 (6.0, 13.2) 2.2 (1.1, 4.4)** 0.9 (0.4, 2.4)
   Primary 715 12.1 (8.5, 17.0) 2.9 (1.5, 5.9)** 1.7 (0.8, 3.6)
  Secondary or higher 419 4.1 (2.2, 7.4) Referent Referent
Wealth index (terciles)
  Low 478 15.1 (10.2, 21.6) 3.7 (1.6, 8.2)*** 1.8 (0.6, 5.0)
  Middle 538 8.5 (5.4, 13.1) 2.1 (0.9, 4.5) 1.2 (0.4, 3.4)
  High 432 4.1 (2.0, 8.2) Referent Referent
‡
PRR = prevalence risk ratio
†
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Table 3
Prevalence and unadjusted and adjusted Prevalence Risk Ratios (PRR) for vitamin B12 deficiency and 
marginal deficiency, Guatemala, ENMICRON 2009–2010
Unadjusted Adjusted
Characteristic N (Unweighted) Prevalence PRR (95% CI) PRR (95% CI)†
(%)
B12 Deficiency (< 148 pmol/L)
National 1448 18.5 (15.6, 21.3)
Area
  Rural 675 21.4 (17.7, 25.6) 0.9 (0.8, 1.0) 1.1 (0.8, 1.5)
  Urban 773 15.4 (11.7, 20.0) Referent Referent
Ethnicity
  Indigeneous 559 19.9 (15.7, 24.9) 1.1 (0.8, 1.5) 0.9 (0.7, 1.2)
  Non-Indigeneous 889 17.6 (14.4, 21.3) Referent Referent
Age (yrs.)
  15 – 19 233 19.3 (14.2, 26.7) Referent Referent
  20 –34 525 15.5 (12.3, 19.4) 0.8 (0.5, 1.2) 0.7 (0.5, 1.1)
  35 – 49 690 20.0 (15.9, 24.9) 1.0 (0.7, 1.5) 0.9 (0.6, 1.4)
Education (yrs)
  None 314 21.3 (15.4, 28.7) 1.6 (1.01, 2.5)* 1.0 (0.6, 1.7)
   Primary 715 20.9 (17.0, 25.4) 1.6 (1.1, 2.3)** 1.2 (0.8, 1.8)
  Secondary or higher 419 13.2 (9.5, 18.1) Referent Referent
Wealth index (terciles)
  Lowest 478 28.2 (22.7, 34.4) 2.6 (1.7, 3.9)*** 2.8 (1.7, 4.8)***
  Middle 538 17.6 13.3, 22.9) 1.6 (1.05, 2.5)* 1.6 (1.02, 2.7)**
  High 432 11.0 (7.6, 15.7) Referent Referent
B12 Marginal Deficiency (148 –221 pmol/L)
National 1448 30.2 (27.3, 33.1)
Area
  Rural 675 29.9 (26.2, 33.9) 1.0 (0.8, 1.2) 1.0 (0.8, 1.2)
  Urban 773 30.4 (26.3, 34.0) Referent Referent
Ethnicity
  Indigeneous 559 25.3 (21.2, 29.9) 0.8 (0.6, 0.9)*** 0.8 (0.6, 1.0)
  Non-Indigeneous 889 33.2 (29.5, 37.0) Referent Referent
Age (yrs.)
  15 – 19 233 37.4 (29.9, 45.5) Referent Referent
  20 –34 525 32.8 (27.8, 38.4) 0.8 (0.7, 1.1) 0.9 (0.7, 1.2)
  35 – 49 690 24.6 (21.2, 28.3) 0.6 (0.5, 0.8)*** 0.7 (0.5, 0.9)***
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Unadjusted Adjusted
Characteristic N (Unweighted) Prevalence PRR (95% CI) PRR (95% CI)†
(%)
Education (yrs)
  None 314 22.6 (17.9, 27.9) 0.7 (0.6, 0.9)*** 0.8 (0.5, 1.1)
   Primary 715 31.0 (26.8, 35.6) 0.9 (0.8, 1.3) 1.0 (0.8, 1.3)
  Secondary or higher 419 33.3 (27.4, 39.7) Referent Referent
Wealth index (terciles)
  Lowest 478 30.9 (26.3, 36.0) 1.0 (0.9, 1.5) 1.7 (1.3, 2.3)***
  Middle 538 28.7 (24.4, 33.4) 0.9 (0.7, 1.3) 1.2 (0.9, 1.5)
  High 432 31.1 (26.3, 36.3) Referent Referent
†
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Table 4
Prevalence and unadjusted and adjusted prevalence risk ratios (PRR) for serum folate and RBC folate 
deficiency and vitamin B12 deficiency and marginal deficiency by region, ENMICRON 2009–2010
N Unadjusted Adjusted†
(unweighted) Prevalence (95% CI) PRR (95% CI) PRR (95% CI)
Serum Folate Deficiency** (<10 nmol/L)
Region
  Metropolitana 141 1.4 (0.3, 6.9) Referent Referent
  Norte 107 8.9 (4.9, 15.7) 5.3(1.0, 29.4)* 1.4 (0.2, 11.7)
  Nor-Oriente 216 5.6 (2.8, 10.7) 3.2 (0.5, 20.7) 1.4 (0.2, 7.5)
  Sur-Oriente 161 7.1 (3.5, 13.7) 4.1 (0.6, 26.8) 2.3 (0.4, 11.9)
  Central 219 6.3 (3.1, 12.4) 3.7 (0.6, 23.8) 2.0 (0.3, 11.6)
  Sur-Occidente 431 5.9 (3.9, 9.1) 3.4 (0.6, 20.3)* 1.7 (0.3, 10.3)
  Nor-Occidente 101 5.2 (1.9, 12.7) 2.9 (0.4, 21.4) 0.9 (0.1, 6.9)
  Petén 72 2.7 (0.7, 10.2) 1.5 (0.2, 13.8) 0.6 (0.1, 5.2)
RBC Folate Deficiency (<340 nmol/L)
Region
  Metropolitana 141 3.5 (0.7, 16.3) Referent Referent
  Norte 107 24.9 (10.0, 49.8) 8.1 (1.2, 43.4)* 2.7 (1.05, 11.9)**
  Nor-Oriente 216 13.9 (8.8, 21.1) 4.4 (1.03, 25.4)* 1.9 (0.4, 8.8)
  Sur-Oriente 161 10.5 (6.5, 16.7) 3.2 (0.6, 18.7) 1.6 (0.3, 7.7)
  Central 219 10.8 (5.3, 20.7) 3.3 (0.5, 20.8) 1.6 (0.3, 8.2)
  Sur-Occidente 431 7.2 (4.6, 10.9) 2.1 (0.4, 12.3) 1.2 (0.2, 5.6)
  Nor-Occidente 101 3.2 (0.8, 12.2) 0.9 (0.1, 8.2) 0.4 (0.1, 2.4)
  Petén 72 3.4 (1.1, 9.8) 0.9 (0.1, 7.3) 0.5 (0.1, 3.2)
Vitamin B12 Deficiency (<148pmol/L)
Region
  Metropolitana 141 14.6 (8.2, 24.6) Referent Referent
  Norte 107 25.8 (15.5, 39.7) 1.8 (0.8, 3.6) 1.1 (0.5, 2.2)
  Nor-Oriente 216 22.8 (16.1, 31.3) 1.6 (0.8, 2.9) 1.1 (0.7, 2.0)
  Sur-Oriente 161 26.1 (19.5, 34.0) 1.8 (0.9, 3.3) 1.4 (0.8, 2.3)
  Central 219 25.6 (18.5, 34.4) 1.7 (0.9, 3.3) 1.4 (0.8, 2.4)
  Sur-Occidente 431 12.3 (8.9, 16.7) 0.8 (0.4, 1.6) 0.6 (0.4, 1.1)
  Nor-Occidente 101 18.7 (9.5, 33.6) 1.3 (0.6, 3.0) 0.7 (0.4, 1.6)
  Petén 72 14.6 (8.6, 23.7) 1.0 (0.5, 2.1) 0.6 (0.3, 1.2)
Vitamin B12 Marginal Deficiency (148 – 221 pmol/L)
Region
  Metropolitana 141 35.2 (28.3, 42,7) Referent Referent
  Norte 107 33.6 (24.7, 43.8) 1.0 (0.7, 1.4) 1.0 (0.7, 1.5)
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N Unadjusted Adjusted†
(unweighted) Prevalence (95% CI) PRR (95% CI) PRR (95% CI)
  Nor-Oriente 216 37.8 (29.5, 46.9) 1.1 (0.8, 1.5) 1.0 (0.7, 1.4)
  Sur-Oriente 161 32.3 (23.0, 43.2) 0.9 (0.6, 1.3) 0.9 (0.6, 1.3)
  Central 219 28.9 (24.0, 34.3) 0.8 (0.6, 1.1) 0.8 (0.6, 1.1)
  Sur-Occidente 431 28.1 (22.6, 34.2) 0.8 (0.6, 1.1) 0.8 (0.6, .1.2)
  Nor-Occidente 101 21.9 (14.2, 32.2) 0.6 (0.4, 0.9)* 0.7 (0.4, 1.1)
  Petén 72 21.5 (12.6, 34.2) 0.6 (0.3, 1.0) 0.6 (0.3, 0.9)*
†
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